GSK189254, a novel H3 receptor antagonist that binds to histamine H3 receptors in Alzheimer's disease brain and improves cognitive performance in preclinical models (Q28574369)
Jump to navigation
Jump to search
scientific journal article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | GSK189254, a novel H3 receptor antagonist that binds to histamine H3 receptors in Alzheimer's disease brain and improves cognitive performance in preclinical models |
scientific journal article |
Statements
2 references
GSK189254, a novel H3 receptor antagonist that binds to histamine H3 receptors in Alzheimer's disease brain and improves cognitive performance in preclinical models (English)
2 references
Kim Brackenborough
2 references
Jackie Cilia
2 references
Barry Crook
2 references
Jane Gartlon
2 references
Teresa Heslop
2 references
Carol Jennings
2 references
Abbe Martyn
2 references
Sandrine Ociepka
2 references
Alison Ray
2 references
Joanne Schogger
2 references
Eric Southam
2 references
Neil Upton
2 references
Graham Wadsworth
2 references
Trevor White
2 references
Jason Witherington
2 references
Angela Worby
2 references
Andrew D Medhurst
Alan R Atkins
Isabel J Beresford
Michael A Briggs
Andrew R Calver
Jane E Cluderay
John B Davis
Rebecca K Davis
Robert P Davis
Lee A Dawson
Andrew G Foley
M Isabel Gonzalez
Warren D Hirst
Declan N C Jones
Ciaran M Regan
Jennifer C Roberts
Tania O Stean
Brenda K Trail
Jeffrey A Wald
Marie L Woolley
David M Wilson
27 February 2007
2 references
321
2 references
3
2 references
Identifiers
2 references
2 references